EUVIMEDEUVIMED entdecken
Crossref

The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity

Lin He, Chunyu Yu, Sen Qin, Enrun Zheng, Xinhua Liu, Yanhua Liu, Shimiao Yu, Yang Liu, Xuelin Dou, Zesen Shang, Yizhou Wang, Yue Wang und 6 weitere

Molecular Cell · 2023-11 · 83 (22) · 4000-4016.e6

DOI: 10.1016/j.molcel.2023.10.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2023-11. Verfasst von Lin He und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodel…. Hauptthemen laut MEDLINE: Histones, Multiple Myeloma. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Peking University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesMultiple MyelomaHumansProteasome Endopeptidase ComplexBortezomibCell Line, TumorDeubiquitinating EnzymesProteasome InhibitorsTrans-Activators

Stichwörter der Autor:innen

19S regulatory particle26S proteasomeNSD2PSMD14RELAbortezomib resistancehistone methylationhistone ubiquitinationmultiple myelomat(4;14) translocation

Substanzen

HistonesProteasome Endopeptidase ComplexBortezomibDeubiquitinating EnzymesProteasome InhibitorsPSMD14 protein, humanTrans-Activators

Autor:innen und Institutionen

  • Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University Health Science Center, Beijing 100191, China; D…
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou 311121, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University International Cancer Institute, Peking University Health Science Center, Beijing 100191, China.
  • Peking University Institute of Hematology, Collaborative Innovation Center of Hematology, Peking University People's Hospital, Beijing 100044, China.
  • Department of Orthopedics, Peking University Third Hospital, Beijing 100191, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University International Cancer Institute, Peking University Health Science Center, Beijing 100191, China; Department of Biochem…

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • Peking University
  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation

Zitieren

APA

He, L., Yu, C., Qin, S., Zheng, E., Liu, X., Liu, Y., Yu, S., Liu, Y., Dou, X., Shang, Z., Wang, Y., Wang, Y., Zhou, X., Liu, B., Zhong, Y., Liu, Z., Lu, J., & Sun, L. (2023). The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity. Molecular Cell, 83(22), 4000-4016.e6. https://doi.org/10.1016/j.molcel.2023.10.019

Vancouver

He L, Yu C, Qin S, Zheng E, Liu X, Liu Y, et al. The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity. Molecular Cell. 2023;83(22):4000-4016.e6. doi:10.1016/j.molcel.2023.10.019

BibTeX
@article{He2023,
  author = {He, Lin and Yu, Chunyu and Qin, Sen and Zheng, Enrun and Liu, Xinhua and Liu, Yanhua and Yu, Shimiao and Liu, Yang and Dou, Xuelin and Shang, Zesen and Wang, Yizhou and Wang, Yue and Zhou, Xuehong and Liu, Boning and Zhong, Yuping and Liu, Zhiqiang and Lu, Jin and Sun, Luyang},
  title = {The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity},
  journal = {Molecular Cell},
  year = {2023},
  volume = {83},
  number = {22},
  pages = {4000--4016.e6},
  doi = {10.1016/j.molcel.2023.10.019}
}
Kostenlos starten →